Atlas Trials

Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

Clinical trial NCT03733340 · UNKNOWN

Trial details

NCT number
NCT03733340
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Antibacterial ProphylaxisHematological MalignanciesAllogenetic Hematopoietic Stem Cell TransplantationImipenem
Start date
2018-12-01
Primary completion
2019-12-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.